← Eichor
Study identifier: NCT02604563 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Aging, Geriatric Syndromes and Clonal Hematopoiesis

Condition: Geriatrics · Aged · Geriatric Syndromes  ·  Sponsor: Washington University School of Medicine

PhaseN/A
Planned participants2000
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

In this study the investigators will incorporate a wide range of clinical variables associated with aging and cardiovascular disease to determine whether they are associated with mutation status independent of chronologic age. Clinically, aging can be operationalized using geriatric assessment, which entails a comprehensive multi-dimensional assessment of the health of an older adult, including measures of comorbidity, polypharmacy, functional status, cognition, depression, falls, social activities and social support. Given that aging is heterogeneous, geriatric assessment allows greater specificity for aging than chronological age alone.

This description comes directly from the study's public registry record.

Talk to the study team

Meagan Jacoby, M.D.  ·  314-747-8439  ·  mjacoby@wustl.edu

Kristina Williams, B.S.  ·  314-362-6963  ·  kjw1@wustl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Washington University School of MedicineSt Louis, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02604563